Based on recent data, Ironwood Pharmaceuticals, Inc. (IRWD) shows an Average True Range (ATR) of 0.39 and an Enterprise Value of 1.89B. Its average trading volume over the past 3 months is 2.5M, indicating liquidity. These fundamental metrics provide insight into IRWD's underlying financial health and market activity.
| ATR | 0.39 |
| Enterprise Value | 1.89B |
| Avg Vol (3 Months) | 2.5M |
| Avg Vol (10 Days) | 3.45M |
Ironwood Pharmaceuticals, Inc. (IRWD) technical indicators as of July 10, 2026: the SMA 20 is -17.42%, SMA 50 at -13.64%, and SMA 200 at 71.49%. The RSI 14 value is 38.3, suggesting its current momentum. These technical analysis signals help assess IRWD's price trends and potential future movements.
| SMA 20 | -17.42% |
| SMA 50 | -13.64% |
| SMA 200 | 71.49% |
| RSI 14 | 38.3 |
Ironwood Pharmaceuticals, Inc. (IRWD) stock performance overview as of July 10, 2026: The 52-week high is $5.78 (currently -36.68% below), and the 52-week low is $0.67 (currently 594.37% above). Over the past year, IRWD's performance is 21.16%, compared to the S&P 500's 5.16% change.
| 52-Week High | 5.78 |
| 52-Week High Chg | -36.68% |
| 52-Week Low | 0.6701 |
| 52-Week Low Chg | +594.37% |
| S&P 500 52-Week Chg | 5.16% |
According to market data, Ironwood Pharmaceuticals, Inc. (IRWD) stock's recent performance metrics show that over the last month, IRWD is 35.91%, with a Year-to-Date (YTD) performance of 35.91%. Over the past year, the stock has seen a 21.16% change. These figures summarize IRWD's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 4.88 | 4.88 | 4.88 | 5.78 | 5.78 | 5.78 |
| Low | 4.27 | 3.2 | 3.15 | 2.95 | 0.6701 | 2.95 |
| Performance | +2.46% | +35.91% | +220.28% | +499.95% | +21.16% | +35.91% |
According to current financial data, IRWD stock's P/E (TTM) ratio is 7.08, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for IRWD, including P/S (2.05), P/B (-3.39), and P/FCF (6.60), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | IRWD | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | 7.08 | -1.22 | 13.5 | 32.59 |
| P/S (TTM) | 2.05 | 3.68 | 6.29 | 5.98 |
| P/B (TTM) | -3.39 | 0.9 | 21.66 | 5.32 |
| P/FCF (TTM) | 6.6 | -39.66 | -8.14 | 30.1 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep